Skip to content
DataLookout
Menu

OEMacroPrLNCT07268183

How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 16 words Show 5 more changesShow less
    • Primary endpoints: details revised at 1 of 11 entries
    • Trial completed
    • Primary completion date changed from estimate of Jan 6, 2027 to Jan 13, 2026
    • Enrollment target: estimated 180 to confirmed 171
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jan 1, 2027 to Jan 6, 2027
    • Start date changed from estimate of Jan 1, 2026 to Jan 6, 2026
    • Site details revised
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

number of patients exposed to combined estrogen-progestin contraception
Timeframe: week 4
number of patients exposed to menopausal hormone therapy
Timeframe: week 4
number of patients exposed to progestin-only treatment
Timeframe: week 4
number of patients exposed to Ovarian Stimulation
Timeframe: week 4
Age at First Use of Hormonal Contraception
Timeframe: week 4
Age at Menarche
Timeframe: week 4
Age at Menopause
Timeframe: week 4
Age at First Live Birth
Timeframe: week 4
Nulliparity
Timeframe: week 4
Number of Pregnancies Carried to Viability
Timeframe: week 4
Exposure to Breastfeeding defined as the total cumulative duration of breastfeeding across all pregnancies, expressed in months. • None: 0-1 month • Moderate: 1-12 months • High: >12 months
Timeframe: week 4

Arms and interventions

Women with a macroprolactinoma

Women with prolactin-producing macroadenomas diagnosed between 2013 and 2023 Followed by the Hospices Civiles de Lyon, Hôpital Cardiologique of Bron.

Women with a microprolactinoma

Women with prolactin-producing microadenomas diagnosed between 2013 and 2023 Followed by the Hospices Civiles de Lyon, Hôpital Cardiologique of Bron.

Other: Standardized questionnaire

Sites

1 site in 1 country

  • Hopital Louis PradelBron, Rhone, France